Categories
Internal Medicine

Metachromatic leukodystrophy (MLD)

Autosomal-recessive inherited lysosomal storage disorder (LSD), characterized by the deficiency of the enzyme arylsulfatase-A (ARSA), or, more rarely, of its activator protein saposin-B.

Autosomal-recessive inherited lysosomal storage disorder (LSD), characterized by the deficiency of the enzyme arylsulfatase-A (ARSA), or, more rarely, of its activator protein saposin-B.


Presentation

Late-infantile MLD (present at 0-3 years):

  • Irritability
  • Developmental delay

Juvenile MLD (present at 4 year-adolescence):

  • Behavioural changes
  • ↓ ability in school

Adult MLD (present after 16 years):

  • Memory loss
  • Psychosis

Complications:

All forms of MLD progress to any of the following:
  • Blindness
  • Paralysis
  • Unresponsiveness
  • Dementia
  • Psychosis

Diagnosis

Blood investigations:

  • Arylsulfatase A (ARSA) enzyme activity in WBC
  • Urine sulfatide levels

Genetic testing:

  • ARSA gene
  • PSAP gene

Brain MRI:

  • Hyperintensification of white matter regions (indicates loss of myelin)

Management

Supportive management

Leave a Reply